Side Effects, Self-Management Activities, and Adherence to Oral Anticancer Agents

References

• Greer JA, Amoyal N, Nisotel L, et al. A systematic review of adherence to oral antineoplastic therapies. Oncologist. 2016;21:354–356. doi:10.1634/theoncologist.2015-040526921292
   PubMed Web of Science ®Google Scholar
• Wood L. A review on adherence management in patients on oral cancer therapies. Eur J Oncol Nurs. 2012;16:432–438. doi:10.1016/j.ejon.2011.10.00222051845
   PubMed Web of Science ®Google Scholar
• Salgado TM, Mackler E, Severson JA, et al. The relationship between patient activation, confidence to self-manage side effects, and adherence to oral oncolytics: a pilot study with Michigan oncology practices. Support Care Cancer. 2017;25:1797–1807. doi:10.1007/s00520-017-3584-028108821
   PubMed Web of Science ®Google Scholar
• Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11:44–47. doi:10.1111/j.1524-4733.2007.00213.x18237359
   PubMed Web of Science ®Google Scholar
• Marsé H, Van Cutsem E, Grothey A, Valverde S. Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®). Eur J Oncol Nurs. 2004;8:S16–S30. doi:10.1016/j.ejon.2004.06.00615341879
   PubMedGoogle Scholar
• Lester J. Safe handling and administration considerations of oral anticancer agents in the clinical and home setting. Clin J Oncol Nurs. 2012;16:E192–E197. doi:10.1188/12.CJON.E192-E19723178361
   PubMedGoogle Scholar
• Geynisman DM, Wickersham KE. Adherence to targeted oral anticancer medications. Discov Med. 2013;15:231–241.23636140
   PubMed Web of Science ®Google Scholar
• Banning M. Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review. Eur J Cancer Care. 2012;21:10–19. doi:10.1111/ecc.2012.21.issue-1
   PubMed Web of Science ®Google Scholar
• Partridge AH, Archer L, Kornblith AB, et al. Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol. 2010;28:2418–2422. doi:10.1200/JCO.2009.26.467120368559
   PubMed Web of Science ®Google Scholar
• Simons S, Ringsdorf S, Braun M, et al. Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care. Support Care Cancer. 2011;19:1009–1018. doi:10.1007/s00520-010-0927-520552377
   PubMed Web of Science ®Google Scholar
• Bhattacharya D, Easthall C, Willoughby KA, Small M, Watson S. Capecitabine non-adherence: exploration of magnitude, nature and contributing factors. J Oncol Pharm Pract. 2012;18:333–342. doi:10.1177/107815521143602222298660
   PubMedGoogle Scholar
• Figueiredo AG Jr, Forones NM. Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer. Arq Gastroenterol. 2014;51:186–191. doi:10.1590/S0004-2803201400030000425296077
   PubMedGoogle Scholar
• Winterhalder R, Hoesli P, Delmore G, et al.; SAEDA Investigators Group (Swiss prospective cohort group. Self-reported compliance with capecitabine: findings from a prospective cohort analysis. Oncology. 2011;80:29–33. doi:10.1159/00032831721606661
   PubMed Web of Science ®Google Scholar
• Zahrina AK, Norsa’adah B, Hassan NB, et al. Adherence to capecitabine treatment and contributing factors among cancer patients in Malaysia. Asian Pac J Cancer Prev. 2014;15(21):9225–9232. doi:10.7314/APJCP.2014.15.21.922525422205
   PubMedGoogle Scholar
• Amlani A, Kumar A, Ruan JY, Cheung WY. Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data. Cancer Med. 2016;5(8):1776–1782. doi:10.1002/cam4.2016.5.issue-827228415
   PubMed Web of Science ®Google Scholar
• Spoelstra SL, Given BA, Given CW, et al. An intervention to improve adherence and management of symptoms for patients prescribed oral chemotherapy agents: an exploratory study. Cancer Nurs. 2013;36:18–28. doi:10.1097/NCC.0b013e318255158723235499
   PubMed Web of Science ®Google Scholar
• Vioral A, Leslie M, Best R, Somerville D. Patient adherence with oral oncolytic therapies. Semin Oncol Nurs. 2014;30:190–199. doi:10.1016/j.soncn.2014.05.00725085031
   PubMedGoogle Scholar
• Kavookjian J, Wittayanukorn S. Interventions for adherence with oral chemotherapy in hematological malignancies: a systematic review. Res Social Adm Pharm. 2015;11:303–314. doi:10.1016/j.sapharm.2014.08.00625262600
   PubMed Web of Science ®Google Scholar
• Fillenbaum GG, Heyman A, Wilkinson WE, Haynes CS. Comparison of two screening tests in alzheimer’s disease. The correlation and reliability of the mini-mental state examination and the modified blessed test. Arch Neurol. 1987;44:924–927. doi:10.1001/archneur.1987.005202100260143619711
   PubMedGoogle Scholar
• Weiss BD, Mays MZ, Martz W, et al. Quick assessment of literacy in primary care: the newest vital sign. Ann Fam Med. 2005;3:514–522. doi:10.1370/afm.40516338915
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The patient health questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284–1292. doi:10.1097/01.MLR.0000093487.78664.3C14583691
   PubMed Web of Science ®Google Scholar
• Ritter PL, Lorig K. The English and Spanish self-efficacy to manage chronic disease scale measures were validated using multiple studies. J Clin Epidemiol. 2014;67:1265–1273. doi:10.1016/j.jclinepi.2014.06.00925091546
   PubMed Web of Science ®Google Scholar
• Merz EL, Roesch SC, Malcarne VL, et al. Validation of interpersonal support evaluation list-12 (ISEL-12) scores among english-and Spanish-speaking Hispanics/Latinos from the HCHS/SOL Sociocultural Ancillary Study. Psychol Assess. 2014;26:384. doi:10.1037/a003524824320763
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–557. doi:10.1016/S0022-3999(99)00057-410661603
   PubMed Web of Science ®Google Scholar
• Walter T, Wang L, Chuk K, Ng P, Tannock IF, Krzyzanowska MK. Assessing adherence to oral chemotherapy using different measurement methods: lessons learned from capecitabine. J Oncol Pharm Pract. 2013;20:249–256. doi:10.1177/107815521350110024022406
   PubMed Web of Science ®Google Scholar
• Nail LM, Jones LS, Greene D, Schipper DL, Jensen R. Use and perceived efficacy of self-care activities in patients receiving chemotherapy. Oncol Nurs Forum. 1991;18:883–887.1891417
   PubMedGoogle Scholar
• National Cancer Institute. Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). 2019 Available from: https://healthcaredelivery.cancer.gov/pro-ctcae/. Accessed 115, 2019.
   Google Scholar
• Lassere Y, Hoff P. Management of hand-foot syndrome in patients treated with capecitabine (Xeloda). Eur J Oncol Nurs. 2004;8(Suppl 1):S31–S40. doi:10.1016/j.ejon.2004.06.00715341880
   PubMedGoogle Scholar
• Gressett SM, Stanford BL, Hardwicke F. Management of hand-foot syndrome induced by capecitabine. J Oncol Pharm Pract. 2006;12(3):131–141. doi:10.1177/107815520606924217022868
   PubMedGoogle Scholar
• Zhao Y, Ding Y, Lu Y, Zhang J, Gu J, Li M. Incidence and self-management of hand-foot syndrome in patients with colorectal cancer. Clin J Oncol Nurs. 2013;17(4):434–437. doi:10.1188/13.CJON.434-43723899983
   PubMed Web of Science ®Google Scholar
• Braik T, Yim B, Evans AT, et al. Randomized trial of vitamin B6 for preventing hand-foot syndrome from capecitabine chemotherapy. J Community Support Oncol. 2014;12(2):65–70. doi:10.12788/jcso.001724971407
   PubMedGoogle Scholar
• Murugan K, Ostwal V, Carvalho MD, et al. Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer. Support Care Cancer. 2016;24(6):2575–2581. doi:10.1007/s00520-015-3061-626715292
   PubMed Web of Science ®Google Scholar
• Thivat E, Van Praagh I, Belliere A, et al. Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors. Oncol. 2013;84:67–74. doi:10.1159/000342087
   Google Scholar
• Buono EW, Vrijens B, Bosworth HB, Liu LZ, Zullig LL, Granger BB. Coming full circle in the measurement of medication adherence: opportunities and implications for health care. Patient Prefer Adherence. 2017;11:1009–1017. doi:10.2147/PPA28652710
   PubMed Web of Science ®Google Scholar
• Devices EH. Electronic tools to measure and enhance medication adherence. US Pharm. 2010;36:6–10.
   Google Scholar
• Wickersham KE, Happ MB, Bender CM, Engberg SJ, Tarhini A, Erlen JA. Surviving with lung cancer: medication-taking and oral targeted therapy. Geriatr Nurs. 2014;35:S49–S56. doi:10.1016/j.gerinurse.2014.02.02024702721
   PubMed Web of Science ®Google Scholar
• Verbrugghe M, Verhaeghe S, Lauwaert K, Beeckman D, Van Hecke A. Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treat Rev. 2013;39:610–621. doi:10.1016/j.ctrv.2012.12.01423428230
   PubMed Web of Science ®Google Scholar
• Seal BS, Anderson S, Shermock KM. Factors associated with adherence rates for oral and intravenous anticancer therapy in commercially insured patients with metastatic colon cancer. J Manag Care Spec Pharm. 2016;22:227–235. doi:10.18553/jmcp.2016.22.3.22727003552
   PubMed Web of Science ®Google Scholar
• Jacobs JM, Pensak NA, Sporn NJ, et al. Treatment satisfaction and adherence to oral chemotherapy in patients with cancer. J Oncol Pract. 2017;13:e474–e485. doi:10.1200/JOP.2016.01972928398843
   PubMed Web of Science ®Google Scholar
• Williams DM, Rhodes RE. The confounded self-efficacy construct: conceptual analysis and recommendations for future research. Health Psychol Rev. 2016;10(2):113–128. doi:10.1080/17437199.2014.94199825117692
   PubMed Web of Science ®Google Scholar
• Stirratt MJ, Dunbar-Jacob J, Crane HM, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5:470–482. doi:10.1007/s13142-015-0315-226622919
   PubMed Web of Science ®Google Scholar
• El Alili M, Vrijens B, Demonceau J, Evers SM, Hiligsmann M. A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol. 2016;82(1):268–279. doi:10.1111/bcp.1294227005306
   PubMed Web of Science ®Google Scholar